In one randomized trial endovenous laser treatment of
the GSV and phlebectomy were followed by sulodexide
twice daily for 1 month and compared with the control
group with no adjunctive pharmacotherapy. compared
with the control group, in the main group there was a
statistically signiÔ¨Åcant decrease in VCSS and improvement in the QOL assessed by CIVIQ-20. The microcirculation of the skin was assessed by laser Dop